NIT Rourkela develops an AI-powered model to improve diabetes management
Co-authored by Prof Baig and his research scholar Deepjyoti Kalita, the findings have been published in the IEEE Journal of ...
Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...